Literature DB >> 18370490

Effect of adverse drug reactions on length of stay in intensive care units.

E Vargas1, J Simón, J C Martin, M Puerro, M A Gonzalez-Callejo, M Jaime, B Gomez-Mayoral, F Duque, A Gomez-Delgado, A Moreno.   

Abstract

The objective of the present study was to determine the frequency of adverse drug reactions (ADRs) in intensive care units (ICUs) and to evaluate their effect on the length of stay. We performed a prospective study to detect ADRs in 420 patients hospitalised in 10 predetermined beds in the ICU of our hospital between the months of March and December 1996. While the patients were staying in the ICU, data was gathered regarding suspected ADRs and on different variables related to the length of stay. 96 different ADRs were detected in 85 of the 420 patients seen [20.2%, 95% confidence intervals (95% CI) 16.5 to 24.4]. The ADRs were most frequently caused by the following drugs: nitrates (n = 25), opiates (n = 21) and ultrashort-acting benzodiazepines (n = 10). Eight ADRs were severe, the suspected medication had to be discontinued in 51 cases and new drugs were necessary to manage the ADRs in 73 cases. The crude estimation of the effect of the number of ADRs performed with a bivariant regression model indicated that each ADR was related to a 2.38-day increase (95% CI 1.31 to 3.45) in the length of stay. Although this estimation was reduced to 1.76 days (95% CI 0.72 to 2.79), when other confounding variables associated with the length of stay were considered, it was still important.In conclusion, the ADRs were a significant clinical problem in the ICUs and were responsible for a significant increase in the length of stay.

Entities:  

Year:  1998        PMID: 18370490     DOI: 10.2165/00044011-199815040-00011

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  43 in total

1.  Drug related admissions to medical wards: a population based survey.

Authors:  J Hallas; L F Gram; E Grodum; N Damsbo; K Brøsen; T Haghfelt; B Harvald; J Beck-Nielsen; J Worm; K B Jensen
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

2.  Adverse drug reactions and death. A review of 827 cases.

Authors:  N S Irey
Journal:  JAMA       Date:  1976-08-09       Impact factor: 56.272

3.  [Iatrogenic pathology in an internal medicine department. II. Adverse reactions to drugs].

Authors:  J L Díez Jarilla; J L Muñoz Bellido; S de Castro del Pozo
Journal:  Med Clin (Barc)       Date:  1986-06-21       Impact factor: 1.725

4.  Drug-induced illness leading to hospitalization.

Authors:  G J Caranasos; R B Stewart; L E Cluff
Journal:  JAMA       Date:  1974-05-06       Impact factor: 56.272

5.  Death after taking medicaments.

Authors:  R H Girdwood
Journal:  Br Med J       Date:  1974-03-16

6.  Epidemiology of adverse drug reactions in intensive care units. A multicentre prospective survey. Italian Group on Intensive Care Evaluation (IGICE).

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 7.  Drug-related hospital admissions.

Authors:  T R Einarson
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

8.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01

9.  Iatrogenic disease in general practice: its incidence and effects.

Authors:  R Mulroy
Journal:  Br Med J       Date:  1973-05-19

10.  Cost of medication-related problems at a university hospital.

Authors:  P J Schneider; M G Gift; Y P Lee; E A Rothermich; B E Sill
Journal:  Am J Health Syst Pharm       Date:  1995-11-01       Impact factor: 2.637

View more
  7 in total

1.  Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.

Authors:  Cristiano Moura; Nília Prado; Francisco Acurcio
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Cardiac arrest and therapeutic hypothermia decrease isoform-specific cytochrome P450 drug metabolism.

Authors:  Jiangquan Zhou; Philip E Empey; Robert R Bies; Patrick M Kochanek; Samuel M Poloyac
Journal:  Drug Metab Dispos       Date:  2011-08-25       Impact factor: 3.922

Review 3.  Drug-related problems in hospitalised patients.

Authors:  P M van den Bemt; T C Egberts; L T de Jong-van den Berg; J R Brouwers
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

4.  Adverse drug events in an intensive care unit of a university hospital.

Authors:  Adriano Max Moreira Reis; Silvia Helena De Bortoli Cassiani
Journal:  Eur J Clin Pharmacol       Date:  2011-01-19       Impact factor: 2.953

Review 5.  Effect of Hypothermia and Targeted Temperature Management on Drug Disposition and Response Following Cardiac Arrest: A Comprehensive Review of Preclinical and Clinical Investigations.

Authors:  Kacey B Anderson; Samuel M Poloyac; Patrick M Kochanek; Philip E Empey
Journal:  Ther Hypothermia Temp Manag       Date:  2016-09-13       Impact factor: 1.286

6.  Mild hypothermia alters midazolam pharmacokinetics in normal healthy volunteers.

Authors:  David Hostler; Jiangquan Zhou; Michael A Tortorici; Robert R Bies; Jon C Rittenberger; Philip E Empey; Patrick M Kochanek; Clifton W Callaway; Samuel M Poloyac
Journal:  Drug Metab Dispos       Date:  2010-02-17       Impact factor: 3.922

7.  Preventable adverse drug events in critically ill HIV patients: Is the detection of potential drug-drug interactions a useful tool?

Authors:  Grazielle Viana Ramos; André Miguel Japiassú; Fernando Augusto Bozza; Lusiele Guaraldo
Journal:  Clinics (Sao Paulo)       Date:  2018-02-19       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.